NASDAQ:CALA

Calithera Biosciences SEC Filings & 10K Form

$2.06
-0.02 (-0.96 %)
(As of 05/7/2021 11:06 AM ET)
Add
Compare
Today's Range
$2.06
$2.11
50-Day Range
$2.05
$2.90
52-Week Range
$2.03
$7.34
Volume7,764 shs
Average Volume1.44 million shs
Market Capitalization$152.54 million
P/E RatioN/A
Dividend YieldN/A
Beta1.77

SEC Filings

Calithera Biosciences (NASDAQ:CALA) SEC Filings

DateFilerForm TypeView
05/06/2021
3:31 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/16/2021
3:41 PM
Calithera Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/16/2021
3:31 PM
Calithera Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
2:32 PM
Calithera Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/12/2021
12:18 PM
Calithera Biosciences (Subject)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
02/12/2021
11:02 AM
Calithera Biosciences (Subject)
Form SC 13G/A
02/11/2021
4:25 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Calithera Biosciences (Subject)
Form SC 13G/A
01/26/2021
4:03 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:06 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Calithera Biosciences (Subject)
Form SC 13G
01/22/2021
7:45 PM
Calithera Biosciences (Issuer)
Hecht Curtis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:44 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:37 PM
Calithera Biosciences (Issuer)
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:36 PM
Calithera Biosciences (Issuer)
Ray Sumita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:33 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:27 PM
Calithera Biosciences (Issuer)
Parlati Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:14 PM
Calithera Biosciences (Issuer)
Sjogren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:13 PM
Calithera Biosciences (Issuer)
Wong Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2021
6:06 AM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
3:27 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:13 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
3:04 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2020
11:15 PM
Calithera Biosciences (Filer)
Form EFFECT
08/19/2020
3:15 PM
Calithera Biosciences (Filer)
Form 424B5
08/10/2020
3:05 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
3:01 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2020
3:05 PM
Calithera Biosciences (Issuer)
Garland J. Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/14/2020
6:30 AM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
3:01 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2020
4:52 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Calithera Biosciences (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2020
3:31 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/13/2020
4:18 PM
Calithera Biosciences (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
03/11/2020
3:41 PM
Calithera Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2020
3:05 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
12:32 PM
Calithera Biosciences (Subject)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
02/07/2020
5:12 AM
Calithera Biosciences (Subject)
DELPHI VENTURES VIII LP (Filed by)
Form SC 13D/A
01/22/2020
5:17 PM
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
5:12 PM
Calithera Biosciences (Issuer)
Wong Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
5:12 PM
Calithera Biosciences (Issuer)
Ray Sumita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
5:09 PM
Calithera Biosciences (Issuer)
Hecht Curtis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
5:07 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:56 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:56 PM
Calithera Biosciences (Issuer)
Parlati Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
4:51 PM
Calithera Biosciences (Issuer)
Sjogren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2020
3:46 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:15 AM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
10:31 AM
Calithera Biosciences (Subject)
PRIMECAP MANAGEMENT CO/CA/ (Filed by)
Form SC 13G
12/26/2019
3:01 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
4:21 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
4:19 PM
Calithera Biosciences (Filer)
Form 424B5
11/22/2019
6:53 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Calithera Biosciences (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2019
5:38 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Calithera Biosciences (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
3:31 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
3:16 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
8:01 AM
Calithera Biosciences (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/31/2019
5:27 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Calithera Biosciences (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
3:16 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:06 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
3:06 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Calithera Biosciences (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/27/2019
3:06 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
3:05 PM
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:05 PM
Calithera Biosciences (Issuer)
Sjogren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:49 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Calithera Biosciences (Subject)
Form SC 13G/A
06/21/2019
3:05 PM
Calithera Biosciences (Issuer)
Wong Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:54 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:50 PM
Calithera Biosciences (Filer)
Form 424B5
06/19/2019
3:06 PM
Calithera Biosciences (Issuer)
Parlati Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:05 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:01 PM
Calithera Biosciences (Filer)
Form 424B5
06/03/2019
3:05 PM
Calithera Biosciences (Issuer)
Wise Blake (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
12:20 PM
Calithera Biosciences (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G/A
05/09/2019
4:01 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2019
3:05 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2019
3:11 PM
Calithera Biosciences (Filer)
Form DEFA14A
04/05/2019
3:06 PM
Calithera Biosciences (Filer)
Form DEF 14A
03/19/2019
3:05 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
3:10 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:32 PM
Calithera Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2019
3:06 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:39 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Calithera Biosciences (Subject)
Form SC 13G/A
02/13/2019
2:10 PM
Calithera Biosciences (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
02/11/2019
3:06 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
3:05 PM
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
Calithera Biosciences (Subject)
Form SC 13G/A
01/14/2019
3:38 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:35 PM
Calithera Biosciences (Issuer)
Sjogren Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:35 PM
Calithera Biosciences (Issuer)
Parlati Francesco (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:33 PM
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:32 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:31 PM
Calithera Biosciences (Issuer)
Hecht Curtis (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:30 PM
Calithera Biosciences (Issuer)
Wong Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:29 PM
Calithera Biosciences (Issuer)
Ray Sumita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2019
3:04 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:03 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2018
3:07 PM
Calithera Biosciences (Issuer)
Molineaux Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:05 PM
Calithera Biosciences (Issuer)
Molineaux Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
4:16 PM
Calithera Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:36 PM
Calithera Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
4:00 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2018
4:00 PM
Calithera Biosciences (Issuer)
Orford Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2018
4:44 PM
Calithera Biosciences (Issuer)
Ray Sumita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.